3D bioprinted tissue
3D Systems Announces Bioprinted Tissue Products for Reconstructive Surgery
3D Systems, the additive manufacturing (AM) pioneer based in South Carolina, has launched the Regenerative Tissue Program, a bioprinting project for patient-specific, living human tissues. By combining the company’s bioprinting…
3D Printing News Briefs, January 14, 2023: ImplementAM, Bioprinted Eye Tissue, & More
In 3D Printing News Briefs today, we’re starting with the launch of a case study-based AM workshop called ImplementAM. In business news, the latest distribution partner for Meltio’s wire laser…
ZEISS Invests in Precise Bio’s Bioprinted Tissue for Corneal Implants
Regenerative medicine startup Precise Bio and Carl Zeiss Meditec (ZEISS), a medical technology company, have begun a partnership for the purposes of developing and commercializing 3D bioprinted corneal tissue for…
3D Printing News Briefs, January 12, 2022: Rebranding, Bioprinting, & More
First up in today’s 3D Printing News Briefs, Particle3D has gone through a rebrand, and a team of researchers developed a way to 3D print and preserve tissues in below-freezing…
3D Printing News Briefs, August 7, 2021: Metal 3D Printer, 3D Printed Bridge, & More
In today’s 3D Printing News Briefs, we’re discussing a new 3D printer from Ace Micromatic Group, and moving on to medical 3D printing news out of T&R Biofab and Tsunami…
3D Printing News Briefs, February 13, 2021: Jilin University, University of Alberta & Royal Military Academy, voxeljet, Google ATAP
We’ve got more research and 3D printed products to share with you in today’s 3D Printing News Briefs, so read on for the details! 3D Bioprinting Tissue & Organoids for…
Keith Murphy: “We Believe We are Discovering the Next Step in Drug Development”
It’s been three years since Keith Murphy and Jeffrey Miner joined forces to create the biotechnology company Viscient Biosciences. In 2017, the co-founders had recently left their previous successful enterprises…
Organovo’s Merger Deal with Tarveda Falls Through, for Now
It has been a stormy few months for the early-stage medical laboratory and research company Organovo. Since announcing a merger deal with Tarveda Therapeutics, a privately-held clinical-stage biopharmaceutical firm, last…
Former CEO of Organovo Urges Stockholders Against Merger with Tarveda
Gaining a competitive advantage is at the core of most businesses. That is why the financial world has a section dedicated exclusively to study the behind-the-scenes of mergers and acquisitions…
